Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2017 October;152(5) > Giornale Italiano di Dermatologia e Venereologia 2017 October;152(5):474-88

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,311


eTOC

 

REVIEW  


Giornale Italiano di Dermatologia e Venereologia 2017 October;152(5):474-88

DOI: 10.23736/S0392-0488.17.05721-2

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Phototherapy for vitiligo, what’s new?

Andrea PARO VIDOLIN, Caterina AURIZI, Giovanni LEONE

San Gallicano Dermatological Institute, IRCCS, Rome, Italy


PDF  


Vitiligo is a disorder characterized by the development of depigmented macules and patches. Existing treatments include topical and systemic immunosuppressants, topical vitamin D analogues in monotherapy or in association with phototherapy, phototherapy and surgical techniques, which together may serve to halt disease progression, stabilize depigmented lesions, and encourage repigmentation. Narrow-band UVB (NB-UVB 310-315 nm) radiation is now considered as the “gold standard” for the treatment of diffuse vitiligo. This article provides a brief overview of the different phototherapy based treatments in vitiligo.


KEY WORDS: PUVA therapy - Phototherapy - Vitiligo

top of page

Publication History

Issue published online: September 12, 2017
Manuscript accepted: July 10, 2017
Manuscript received: July 3, 2017

Cite this article as

Paro Vidolin A, Aurizi C, Leone G. Phototherapy for vitiligo, what’s new? G Ital Dermatol Venereol 2017;152:474-88. DOI: 10.23736/S0392-0488.17.05721-2

Corresponding author e-mail

giovanni.leone@ifo.gov.it